Tonix Pharmaceuticals Holding CORP. (TNXP) — 8-K Filings

All 8-K filings from Tonix Pharmaceuticals Holding CORP.. Browse 45 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (45)

Tonix Pharmaceuticals Files 8-K with Presentations — Mar 31, 2026 Risk: medium
Tonix Pharmaceuticals Holding Corp. filed an 8-K on March 31, 2026, reporting on events from March 30, 2026. The filing includes a press release and corporate p
8-K Filing — Dec 29, 2025
8-K Filing — Dec 16, 2025
Tonix Pharma Files 8-K on Dec 9, 2025 — Dec 9, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on December 9, 2025, reporting on events including a Regulation FD Disclosure, Other Events, and Financial Stat
Tonix Pharmaceuticals Files 8-K — Nov 24, 2025 Risk: low
On November 24, 2025, Tonix Pharmaceuticals Holding Corp. filed an 8-K report. The filing indicates a Regulation FD Disclosure and Other Events. The company's p
8-K Filing — Nov 21, 2025
8-K Filing — Nov 18, 2025
Tonix Pharmaceuticals Files 8-K — Nov 17, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on November 17, 2025, reporting on other events and financial statements. The filing does not disclose specific
Tonix Pharma Files 8-K on Operations and Other Events — Oct 27, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on October 27, 2025, reporting on its results of operations and financial condition, as well as other events. T
Tonix Pharmaceuticals Files 8-K — Oct 22, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on October 22, 2025, reporting on other events and financial statements. The filing indicates the company's pri
Tonix Pharmaceuticals Files 8-K — Oct 7, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on October 7, 2025, reporting on various events. The filing includes information related to financial statement
Tonix Pharmaceuticals Files 8-K on Sept 30, 2025 — Sep 30, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on September 30, 2025, reporting on events including a Regulation FD Disclosure, Other Events, and Financial St
Tonix Pharmaceuticals Files 8-K — Sep 29, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on September 29, 2025, reporting on other events and financial statements. The company, incorporated in Nevada,
Tonix Pharmaceuticals Files 8-K — Sep 18, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on September 18, 2025, reporting on other events and financial statements. The company, incorporated in Nevada,
Tonix Pharmaceuticals Files 8-K — Sep 17, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on September 17, 2025, reporting on other events and financial statements. The filing indicates the company's p
Tonix Pharmaceuticals Files 8-K — Aug 18, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on August 18, 2025, reporting on other events and financial statements. The filing details the company's princi
Tonix Pharmaceuticals Files 8-K — Aug 15, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on August 15, 2025, reporting on events that occurred on the same date. The filing indicates it is a current re
Tonix Pharmaceuticals Files 8-K — Jul 25, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on July 25, 2025, reporting on its results of operations and other events. The filing does not contain specific
Tonix Pharmaceuticals Files 8-K — Jul 21, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on July 21, 2025, reporting on other events and financial statements. The filing does not contain specific fina
Tonix Pharmaceuticals Files 8-K — Jul 16, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on July 16, 2025, reporting on other events and financial statements. The filing details the company's corporat
Tonix Pharmaceuticals Files 8-K — Jul 10, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on July 10, 2025, reporting on other events and financial statements. The company, incorporated in Nevada, is b
Tonix Pharmaceuticals Relocates Offices, Updates Contact Info — Jul 9, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on July 9, 2025, reporting on other events and financial statements. The filing indicates a change in the compa
Tonix Pharmaceuticals Files 8-K — Jul 2, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on July 2, 2025, reporting on other events and financial statements. The filing indicates the company's princip
Tonix Pharmaceuticals Files 8-K — Jun 16, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on June 16, 2025, reporting on other events and financial statements. The filing does not contain specific fina
Tonix Pharma Files 8-K: Officer/Director Changes & Compensation — Jun 13, 2025 Risk: medium
Tonix Pharmaceuticals Holding Corp. filed an 8-K on June 13, 2025, reporting on events from June 12, 2025. The filing indicates changes in directors or officers
Tonix Pharmaceuticals Files 8-K with Material Agreement — Jun 11, 2025 Risk: medium
On June 11, 2025, Tonix Pharmaceuticals Holding Corp. filed an 8-K report detailing a material definitive agreement. The filing also includes financial statemen
Tonix Pharmaceuticals Files 8-K — May 21, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on May 21, 2025, reporting on other events and financial statements. The filing does not disclose specific new
Tonix Pharmaceuticals Files 8-K — May 14, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on May 14, 2025, reporting on various events. The filing includes information related to Regulation FD Disclosu
Tonix Pharmaceuticals Files 8-K on Security Holder Vote — May 8, 2025 Risk: medium
Tonix Pharmaceuticals Holding Corp. filed an 8-K on May 8, 2025, reporting on the submission of matters to a vote of security holders. The filing does not conta
Tonix Pharmaceuticals Files 8-K — Apr 29, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on April 29, 2025, to report on various events. The filing includes information related to Regulation FD Disclo
Tonix Pharmaceuticals Files 8-K — Apr 25, 2025 Risk: medium
Tonix Pharmaceuticals Holding Corp. filed an 8-K on April 25, 2025, reporting on its results of operations and other events. The filing details the company's fi
Tonix Pharmaceuticals Files 8-K With Exhibits — Apr 24, 2025 Risk: low
On April 23, 2025, Tonix Pharmaceuticals Holding Corp. filed an 8-K report. The filing primarily consists of financial statements and exhibits, with no specific
Tonix Pharmaceuticals Files 8-K — Apr 9, 2025 Risk: medium
Tonix Pharmaceuticals Holding Corp. filed an 8-K on April 9, 2025, reporting on events including a Regulation FD Disclosure and Other Events. The filing also in
Tonix Pharmaceuticals Files 8-K — Apr 1, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on April 1, 2025, reporting on events including a Regulation FD Disclosure, Other Events, and Financial Stateme
8-K Filing — Mar 24, 2025
Tonix Pharmaceuticals Files 8-K — Mar 10, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on March 10, 2025, reporting on various events. The filing includes information on financial statements and exh
8-K Filing — Mar 4, 2025
Tonix Pharma Files 8-K: Director Changes & Officer Compensation — Mar 4, 2025 Risk: medium
Tonix Pharmaceuticals Holding Corp. filed an 8-K on February 27, 2025, reporting on the departure of directors, election of new directors, and compensatory arra
Tonix Pharmaceuticals Files 8-K Under 'Other Events' — Feb 21, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on February 21, 2025, reporting an event on February 20, 2025. The filing is categorized under 'Other Events' a
Tonix Pharma Relocates Executive Offices — Feb 7, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on February 7, 2025, reporting on events that occurred on the same date. The filing indicates a change in the c
Tonix Pharmaceuticals Files 8-K — Feb 6, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on February 6, 2025, reporting on its corporate activities. The filing confirms the company's principal executi
Tonix Pharma Files 8-K on Officer/Director Changes & More — Feb 4, 2025 Risk: medium
Tonix Pharmaceuticals Holding Corp. filed an 8-K on February 4, 2025, reporting events as of February 3, 2025. The filing covers the departure of directors or c
Tonix Pharmaceuticals Terminates Material Agreement — Feb 3, 2025 Risk: medium
Tonix Pharmaceuticals Holding Corp. filed an 8-K on February 3, 2025, reporting the termination of a material definitive agreement and other events. The filing
Tonix Pharmaceuticals Files 8-K — Jan 8, 2025 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on January 8, 2025, reporting on other events and financial statements. The filing indicates the company's prin
Tonix Pharmaceuticals Files 8-K — Dec 23, 2024 Risk: low
Tonix Pharmaceuticals Holding Corp. filed an 8-K on December 23, 2024, reporting on other events and financial statements. The filing indicates the company's pr

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX